CancerX Startup Accelerator
Cohort 2025
CancerX Accelerator class will be announced at Vive on Feb 17, 2025.
About CancerX
The CancerX Accelerator program catalyzes innovation in cancer research, prevention and treatment by bringing together cross industry champions, leading investors and promising startups to accelerate solutions to address real-world gaps in care and patient unmet needs, personalized treatments, reducing costs, advancing use of AI to drive quality cancer care for all patients, and empowering patients and their families.
Together, we are laser-focused on ending cancer as we know it. The CancerX community has unparalleled multi-stakeholder subject matter expertise that doesn’t accept the status quo that is failing patients and families in cancer care. We are on a relentless quest to supercharge digital health innovations to improve the lives of patients, families, providers and the communities they serve.
CancerX Startup Accelerator
Cohort 2025 Themes
Quality
Care For All
Addressing gaps in care for all patients to access quality cancer care through developing data analytics and AI tools, improving resource navigation, and modernizing and streamlining workflows and processes.
Clinical Trial
Acceleration
Developing approaches and tools (including AI) to expedite the eligibility and accessibility of clinical trials for patients, while optimizing the technology and data for clinical researchers targeting improved care outcomes.
Connected & Individualized Care – Care beyond the clinic
Delivering personalized, seamless, and connected care for patients and their support community. Enabling monitoring of patients across the care pathway and beyond the clinic.
Our Program
The CancerX Accelerator offers startups a unique opportunity to propel their solutions by providing critical resources, support, networking and connections across industry leadership and the public sector through our collaboration with the federal government
Who You Are
Startups eligible for the program must have a validated product or solution ready for scaling, with at least two completed proof of concept(pilots) involving at least 50 patients living with cancer in clinical settings. Companies should have a minimum of 10 full-time employees, including a designated liaison to engage with the selection team during the accelerator. We’re excited to invite pediatric oncology companies to the CancerX Accelerator partnership with KidsX. If you have a pediatric focused solution, we invite you to apply. Learn more.
Join us to harness the power of innovation to reduce the burden of cancer for all people.
Committed Champions Accelerating Growth
Gain the ability to be matched with leading healthcare organizations and investors to pursue validation, refine product/market fit and obtain funding.
Exclusive Mentor
Network
Access a high-engaged mentorship network of doers who are committed to the success of selected startups with deep expertise in digital health and oncology. Benefit from expert guidance, support, and resources throughout the program, helping you navigate the complexities of healthcare innovation.
Network Targeted Programming
Offer startups a tailored curriculum based on your strategic objectives. The programming combines virtual and in person events to foster learning and networking with key stakeholders across the public and private sector.
2025 Champions
Key Dates
Nov 18, 2024
2025 Cohort Application Close
Feb 2025
2025 Cohort Announcement at ViVE 2025
Mar - Jun, 2025
2025 Cohort Accelerator Programming
Jun, 2025
2025 Cohort Demo Day Showcase
Sep, 2025
2026 Cohort Applications Open
2024 Accelerator Impact
The Atrium Health team has been an outstanding development partner and champion for us at Lind during the CancerX accelerator. Over the past six months, their unparalleled commitment of time, expertise, and access to over 50 clinicians has truly demonstrated Atrium’s dedication to innovation. Throughout our collaboration, consistent themes have emerged—Atrium’s compassionate patient-first approach, commitment to delivering exceptional care, drive for safe innovation, and remarkable clinical expertise have truly set them apart. We at Lind are deeply grateful for the support we’ve received and look forward to continuing our partnership to offer every patient access to clinical trials as part of their care journey, by reducing the operational challenges of trial matching and discovery.
-Oggie Nikolic, CEO @ Lind
Our business model uses AI for summarization and second opinions. We didn’t think the process we built out to assist with our final goal (retrieving and organizing medical records quickly and meaningfully) was the piece that made all the difference to Moffitt. Because of the CancerX Accelerator, we are thrilled to have our product tested out to solve for record retrieval, something we previously have not pursued uniquely. The way Moffitt as a health system framed their use cases achieves outcomes we hadn’t thought of and expands use cases our product can make an impact for. It is also equally exciting that Moffitt and Navya are learning together about how best to leverage AI, and I think we will emerge stronger together.”
-Naresh Ramarajan,
MD. Chief Medical Officer, Navya
We are excited to pilot our AI-driven clinical workflow technology at Moffitt Cancer Center as part of the CancerX Accelerator’s inaugural cohort. We appreciate the opportunity to pilot our technology in a real world clinical setting to evaluate its impact on clinical efficiency, operational excellence and patient experience. Moffitt’s leadership in being an early evaluator and adopter is key to a sustainable and scalable healthcare innovation.
Together Employed
Have Collectively
Generated Revenue
This program made a significant impact on the lives of millions of cancer patients, aiming to cut the death rate from cancer by at least 50% over the next 25 years. The accelerator program proudly supported market innovation, job creation, and economic impact.
2024 Startups
2024 Champions
2024 Startups
2024 Champions
Frequently Asked Questions
How are applications for the Accelerator program evaluated?
Applications are evaluated based on a combination of factors, including the alignment to the CancerX Accelerator themes, product market fit, the expertise of your founding team, and the impact your startup could have. We also look for innovation, scalability, and your startup’s potential for growth.
What is the judging process?
If your application is successful, you will be notified by the CancerX Accelerator team by December 4, 2024. Following this, you will be invited to participate in our Pitch Days, which will take place on December 10, 11, and 12. You’ll be able to select a time slot that works best for your team. Detailed instructions will be provided, including what to include in your pitch presentation and how to prepare for the pitch process.
What are the theme areas?
Quality Care for All
Driving quality care access through developing data analytics and AI tools, improving resource navigation, and building effective processes.
Theme elements include:
- Match patient needs to support mechanisms e.g., financial resources, caregiver support
- Provide care closer to home
- Reduce the time to right treatment
- Embed predictive analytics in care settings to proactively identify health related social needs and drive patient engagement
- Develop communication tools that are appropriate for each patient e.g., adult and pediatric populations, range of languages, styles of communication
- Improving access to pediatric cancer care by addressing unique
barriers like family-centered support, transportation, and child-friendly care
navigation, ensuring all children receive quality care regardless of location
or resources
Clinical Trial Acceleration
Developing approaches and tools (including AI) to expedite the eligibility and accessibility of clinical trials for patients, while optimizing the technology and data for clinical researchers targeting improved care outcomes.
Theme elements include:
- Enhance the speed and accuracy of reviewing the latest cancer literature and research
- Mine public data sources to identify current research studies, collaborators and partners
- Develop tools for statistical analysis, multi-modal classifications and quality metrics tracking, and submissions
- Create tools that improve the efficiency of research report development
- Build tools to support pragmatic trials and scale advanced testing
- Design tools to support the acceleration of drug trials and approvals
- Accelerate and improve the clinical trial eligibility process. Develop technology to make it easier to offer clinical trials in rural and other underserved areas
- Improve pediatric cancer clinical trial access by leveraging AI for trial matching, and designing child-specific trials that minimize disruption to education and daily life, ensuring better outcomes for rare pediatric cancers
Connected & Individualized Care- Care beyond the clinic
Delivering personalized, seamless, and connected care for patients and their support community. Enabling monitoring of patients across the care pathway and beyond the clinic.
Theme elements include:
- Connect providers, patients and caregivers more effectively, and reduce administrative burdens
- Ensure proactive goals of care discussions
- Provide personalized patient education and resources
- Improve monitoring across the care continuum and support care transitions
- Improve management of oral therapeutics and maintenance drugs taken at home to monitor medication adherence/ compliance
- Ensure continuous pediatric cancer care through home-based solutions, mental health support, and tools for smooth transitions to adult care, focusing on long-term survivorship and developmental tracking
What can I expect if I’m in the accelerator?
We will be inviting the final cohort to attend Vive for the announcement.
We will share more details to finalists about in person events, but please expect travel to on-site events in March (Tampa), April/May (site to be confirmed), July (showcase in Boston). We will confirm final details for you and your team to plan accordingly.
We will also be hosting virtual curriculum sessions once a month across a variety of topics for example: Innovation in Government, Front Lines of Healthcare, Scaling your Business, Partnering with Industry. The CancerX accelerator will send communications for program details once the Accelerator begins.
This is a very hands-on and targeted program and the more you can participate and be involved, the more benefits you will gain for your accelerator experience.
We will work together towards a successful outcome for you during the course of the accelerator but cannot guarantee results.
How do the champions get engaged?
Our champions are closely involved in the selection process and the finalists in our 2025 cohort will have 1 or more champions leaning in to accelerate your company. Each champion will meet with you and discuss goals and approach. Recognize they are large organizations with many complexities so be prepared and be patient. The accelerator team is here to help you along the journey.
How is CancerX partnering with KidsX?
This year, we are excited to announce the collaboration with KidsX. We are inviting pediatric focused oncology solutions in the challenge themes above. When you apply, you will select your interest in being considered for the KidsX/CancerX cohort. We expect to accept 2 finalists in this cohort. The target patient population for KidsX applications is 0-18 years old.
I have more questions, who can I contact to ask?
We welcome your questions. Please email accelerator@cancerx.health
If I applied, when will I be updated about the status of my application?
The 2025 cohort will be announced at ViVE (mid February) so all applicants will have an update on the status of their application by then.
When is the cohort going to be announced?
The cohort will be announced during the ViVE conference (Feb 16-19)
